Vetter Pharma Company Profile and Achievements

Vetter Pharma is a leading company in the contract development and manufacturing of drug delivery systems.

Founded in 1983, Vetter has been in the industry for over 39 years.

Vetter's headquarters is located in Ravensburg, Germany.

The company has expanded its operations to include a second site in Ravensburg, as well as a location in Kaiserslautern, Germany.

Vetter employs over 5,000 highly skilled and dedicated professionals worldwide.

Their team includes experts in various fields, such as pharmaceuticals, engineering, and quality management.

Vetter Pharma continues to make significant strides in the US market, expanding its presence to meet increasing customer demands.

The company has outlined the location and design of its new manufacturing sites, indicating a focus on growth and development.

Vetter's expansion in the US is a key aspect of its strategy to increase its global reach and provide more services to its customers.

The new manufacturing sites will be designed to meet the company's high standards for quality and efficiency, ensuring that its customers receive the best possible products and services.

A unique perspective: Apple Is Building Its Fourth Assembly Plant in India

Vetter Pharma is clearly on a path of steady growth and expansion. They're looking to meet the increasing demand in the supply chain for complex injectable medications.

Ongoing investments in the supply chain are a key part of their strategy. This will help them keep up with the growing need for these types of medications.

Vetter is also boosting their pharmaceutical storage capacity with a major warehouse expansion. This will double their cool storage volume by 2028.

Their focus on supply chain efficiency will likely pay off in the long run, allowing them to deliver medications to patients in a timely and reliable manner.

You might enjoy: Pharma Cold Chain Logistics Companies

Vetter Pharma specializes in developing and manufacturing injectable drugs, which are sterilely filled into syringes and other injection systems.

The company's expertise lies in filling active ingredients for various diseases, including rheumatism, Crohn's disease, and rare diseases such as Alzheimer's in children.

Vetter's facilities in Ravensburg and Langenargen are where the magic happens, with the company filling and packaging ingredients for autoimmune diseases like rheumatism and Crohn's disease.

The company has a diverse customer base, serving over 200 clients that include large pharmaceutical companies and numerous biotech startups.

Vetter Pharma has received the Sustainable Impact Award in 2022 and 2023 for its commitment to social impact. The award is given by Wirtschaftswoche, the Bundesverband mittelständische Wirtschaft, and Generali Deutschland.

In 2023, Vetter won the Sustainable Impact Award for the second time, this time in the "Impact of Social Engagement" category.

Vetter received the German Federal Ministry for the Environment's Environmental Management Award in 2023.

Vetter Pharma has a dynamic leadership team that is constantly evolving. Managing Director Peter Sölkner has left the company.

Carsten Press has taken over the relevant departments, ensuring a smooth transition. He is well-equipped to handle the responsibilities.

Tilman Roedle is the Lead Expert Drug Delivery Systems for Vetter. He focuses on strategic industry collaborations and Quality Management for medical devices.

Peter Sölkner has left his position as Managing Director at Vetter.

He has been replaced by Carsten Press, who will be taking over the relevant departments.

Carsten Press is now in charge of managing the departments that previously fell under Peter Sölkner's responsibility.

Tilman Roedle is the Lead Expert Drug Delivery Systems for Vetter.

He deals intensively with strategic industry collaborations on innovative drug delivery systems.

Tilman's work involves Quality Management for medical devices, ensuring that products meet the highest standards.

This expertise allows Vetter to stay ahead in the industry, providing cutting-edge solutions for patients.

Dr. Gerhard Reuter is a veteran quality specialist at Vetter.

He plays a critical role in authorizing the release of medical product batches.

Dr. Reuter oversees the quality systems used to produce these products.

His expertise ensures that medical products meet the highest standards of quality and safety.

Vetter Pharma has a strong strategic alliance with Rentschler Biopharma, which has taken key steps forward.

The two companies have further strengthened their collaboration, taking their partnership to the next level. This move is a testament to the trust and mutual respect between Vetter and Rentschler Biopharma.

Their strategic collaboration has been a key factor in Vetter's success, enabling them to provide top-notch services to their clients.

Vetter Pharma is a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and biotechnology industry.

The company was founded in 1993 by Heinrich Schaller and Rainer M. Schaller in Ravensburg, Germany.

Vetter has grown to become a global player with a strong presence in Europe, North America, and Asia.

The company's headquarters is located in Ravensburg, Germany, where it was founded over 25 years ago.

Vetter's global network includes manufacturing facilities in Germany, the United States, and Malaysia.

The company's expertise lies in the development and manufacturing of complex drug products, including prefilled syringes, cartridges, and vials.

Vetter has a strong focus on quality, regulatory compliance, and patient safety.

The company has a reputation for delivering high-quality products and services to its customers.

Vetter's commitment to innovation and technology has led to the development of cutting-edge manufacturing solutions.

The company's global team consists of over 4,500 employees from diverse backgrounds and expertise.

Vetter's headquarters in Ravensburg, Germany, serves as a hub for research and development, quality management, and business operations.

The company's global network allows it to provide fast and flexible services to its customers worldwide.

Suggestion: New Development Bank